2017: BEYOND MEASURE

Abbott recognized as industry leader on Fortune's Most Admired

2017: Beyond Measure

Jan 19 2018

How to measure a year.

To our 94,000 employees, 2017 was tens of millions of lives touched by our innovations. Every single day. It was 8 million babies nourished; 10,000 hearts healthier; thousands of people living with less pain and fewer tremors; 400,000 people with diabetes freed from the routine fingerstick1; millions of people with the health information they needed from our diagnostic tests to make some of their biggest life decisions.

It all adds up – Fortune recently recognized us as the 2017 top medical products and equipment company on its Most Admired Companies list, for the fifth consecutive year.

 

 

Our life-changing health technologies have been recognized elsewhere: We've been named a Top 100 Global Innovator four years in a row. We are consistently named a Science 2017 Top Employer by Science magazine. We were recognized as one of the 30 greatest stocks of all time by Kiplinger and were recently named Medtech Company of the Year. Our citizenship efforts are also well recognized; Dow Jones Sustainability Index named us the global industry leader for the fifth consecutive year in 2017.

We are proud that our company's success enabled us to support the communities where we live and work, doing things like enhancing rice fortification technology to fight malnutrition and filling backpacks with nutritious foods for children in the U.S. Forty-five thousand students and their family members had the opportunity to discover a love of science through our educational programs. And we helped prepare more than 50 clinics and food banks for hurricane season – and when disaster struck, we donated $4.25 million for relief.

But it's the stories behind these numbers that inspire us.

It's Charlene Johnson, a woman with essential tremor, who can now drink a glass of water and brush her teeth normally again thanks to our deep brain stimulation device. Kato Pomer, whose ruptured mitral valve was repaired with our MitraClip2 device at 92 (she recently celebrated her 100th birthday). And baby Djaliou, who was nourished and grew to a healthy weight with our infant formula – qualifying him for a life-saving surgery on a hospital ship Abbott supports.

As we size up 2017, we'll measure by smiles of triumph, tears of relief – by "impossibles" made possible. We'll take a moment to let those measures fill us up, and to drive us to innovate even more in 2018.

 

References

1. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
2. For important safety information, visit: https://mitraclip.com/#isi

 

 

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?